Biotage AB (publ) – board member Staffan Lindstrand leaves his assignment

Staffan Lindstrand, partner of HealthCap, has today given notice that he leaves his assignment as member of Biotage’s Board of Directors.

HealthCap sold its entire shareholding in Biotage at the end of August 2010. 

Biotage discloses the information provided herein pursuant to the Swedish Securities Markets Act and/or the Swedish Financial Instruments Trading Act. The information was submitted for publication at 10.30am CET on 27 October 2010.

Contact: 
Torben Jörgensen, President and CEO
Tel: +46 707 49 05 84, torben.jorgensen@biotage.com            

About Biotage
Biotage offers solutions, knowledge and experience in the areas of analytical chemistry and medicinal chemistry. The customers include the world’s largest pharmaceutical and biotech companies, and leading academic institutes. The company is headquartered in Uppsala and has subsidiaries in the US, UK and Japan. Biotage has 269 employees and had sales of 394.1 MSEK in 2009. Biotage is listed on the NASDAQ OMX Nordic Stockholm stock exchange. Website: www.biotage.com